Mediliant Group Welcomes Christophe Schindler as New CFO
The addition of Christophe to the leadership team further enhances the Mediliant Group's strategic growth plan.
LE LOCLE, Switzerland, April 26, 2022 /PRNewswire-PRWeb/ -- Leaders in medical device contract manufacturing, Mediliant Group, has today announced the addition of Christophe Schindler as their new Chief Financial Officer (CFO). The addition of Mr. Schindler was a part of the strategic growth plan for the group as they continue to expand and strengthen the organization's leadership team.
With over 27 years of experience in finance leadership, Christophe brings to the organization extensive skills and expertise in areas including financial and services management, strategy and business planning, mergers and acquisitions, forecasting and planning, as well as risk management. He is also an accomplished CFO and Services Director from small to large domestic and international companies in various industries ranging from MedTech to Pharma and Biotech.
"I joined the Mediliant Group because of their solid strategy and ambition for growth. Their current global presence and the CMO market focus on the spine, trauma and extremity shows a strategic vision and discipline. I'm intrigued by the Mediliant Group's growth through M&A and am excited by the opportunities to acquire new technologies that will help meet our customer's needs." - Christophe Schindler
The Mediliant Group has calculated growth plans that are targeted primarily through mergers and acquisitions. As the new CFO for the organization, Christophe will assist in providing the fiscal discipline that is needed to direct Mediliant Group towards positive outcomes and fulfill their vision of becoming a global leader in the Medical Device Industry while also strengthening their capabilities in extremities, spine, and trauma.
For more information about Christophe Schindler and the Mediliant Group visit Mediliant.com.
About Mediliant Group
The Mediliant Group is an international contract manufacturer that is specifically focused on complex orthopedic implants for the Spine, Extremity and Trauma markets. (S.E.T.) Our multi-site footprint consists of 3 manufacturing locations: CTE Solutions (Plymouth, IN), MDI (Lancaster, PA) and Mediliant Switzerland (LeLocle, CH).
The Mediliant Group share a similar corporate culture, entrepreneurial spirit, and a customer centered approach to business. We want to be your partner for manufacturing medical devices with our focus being on improving lives, together. We believe that together we can positively impact lives, that success comes from integrity, serving others, and a relentless quest for perfection, and that all problems can be solved with dedication, creative thinking, and personal care.
Media Contact
Philip Penn, Mediliant Group, 1 619-894-6162, [email protected]
SOURCE Mediliant Group
Share this article